# ACTEMRA

NDC: 50242-137
Generic name: tocilizumab
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20100108

FDA application: BLA125276

## Active ingredients

- TOCILIZUMAB: 400 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-137"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-137
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13